So far, in addition to age, alcohol consumption, duration of RA, serum albumin level, obesity, and pre-existing pulmonary fibrosis, the cumulative dose and duration of MTX use have been reported as risk factors for histological fibrosis or cirrhosis in patients with RA receiving MTX [19-21]. The gene discussed is ALB; the disease is Cirrhosis.